Escient Pharmaceuticals Inc — Form D/A
Escient Pharmaceuticals Inc of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2020-09-18. The offering totals $77.5M, of which $38.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-18
- Form: D/A
- Accession: 0001736699-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $77.5M
- Amount sold: $38.8M
- Remaining: $38.8M
- Investors: 18
- Date of first sale: 2020-08-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374864
Issuer
- Name: Escient Pharmaceuticals Inc
- CIK: 0001736699
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA, 92121
- Phone: (858) 617-8220
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Alain Baron | Director | San Diego, CA |
| Kathleen Glaub | Director | San Diego, CA |
| Jason Hafler | Director | South San Francisco, CA |
| Peter Hirth | Director | South San Francisco, CA |
| JeenJoo Kang | Director | San Francisco, CA |
| Kevin Raidy | Director | Thousand Oaks, CA |
| Andrew Schwab | Director | BOSTON, MA |
| Charles Zuker | Director | San Diego, CA |
| Alain Baron | Executive Officer | San Diego, CA |
| Kathleen Sereda Glaub | Director | San Carlos, CA |
| Robert Tjian | Director | South San Francisco, CA |
| Peter Sereda Hirth | Director | San Diego, CA |
| Charles Sereda Zuker | Director | San Diego, CA |
| Jason Sereda Hafler | Director | San Diego, CA |
| Kevin Sereda Raidy | Director | San Diego, CA |
| Aaron Sereda Mishel | Executive Officer | San Diego, CA |
| Joshua Grass | Director | San Diego, CA |
| Joshua Grass | Executive Officer | San Diego, CA |
| JeenJoo Sereda Kang | Director | San Diego, CA |
| Andrew Sereda Schwab | Director | San Diego, CA |
| Marcus Boehm | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More